ArticleFrontiers in microbiology2019
NrtR Regulates the Type III Secretion System Through cAMP/Vfr Pathway in
Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- TypA Interacts with ExsA to Suppress Type III Secretion System inMicroorganisms · 2026Article
- PA5201 represses type III secretion system by binding to the PMicrobiology spectrum · 2026Article
- Injectisome assembly primesmBio · 2026Article
- Hemolytic mechanism and virulence of Antarctic psychrophilicFrontiers in microbiology · 2026Article
- Plasmid replication initiator protein TrfA represses the host type III secretion system inmBio · 2025Article
- Pathogenicity and virulence ofVirulence · 2025Review
- Regulation of NADPathogens (Basel, Switzerland) · 2025Article
- The Catabolite Repression Control Protein Crc Regulates the Type III Secretion System Through the Adenylate Cyclase CyaB inMicroorganisms · 2025Article
- Hyperpiliation, not loss of pilus retraction, reducesMicrobiology spectrum · 2025Article
- Development of genetic manipulation tools forFrontiers in microbiology · 2025Article
- Toxin-mediated depletion of NAD and NADP drives persister formation in a human pathogen.The EMBO journal · 2024Article
- The transcriptional regulators of virulence forGenes & diseases · 2023Review
- NrtR Mediated Regulation of H1-T6SS in Pseudomonas aeruginosa.Microbiology spectrum · 2022Article
- RplI interacts with 5' UTR of exsA to repress its translation and type III secretion system in Pseudomonas aeruginosa.PLoS pathogens · 2022Article
- OsaR (PA0056) Functions as a Repressor of the GeneJournal of bacteriology · 2021Article
- Cautionary Notes on the Use of Arabinose- and Rhamnose-Inducible Expression Vectors in Pseudomonas aeruginosa.Journal of bacteriology · 2021Article
- High-density transposon libraries utilising outward-oriented promoters identify mechanisms of action and resistance to antimicrobials.FEMS microbiology letters · 2020Article
- Fitting Pieces into the Puzzle ofJournal of bacteriology · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The type III secretion system (T3SS) plays an important role in the pathogenesis of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.